Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?

Chatzimichail E, Pfau K, Gatzioufas Z, Panos GD

Drug Design, Development and Therapy 2024, 18:365-374

Published Date: 8 February 2024